Skip to content

MEDECO

Active
Public limited companyfounded 200620 yrs activeSatenrozen 19, 2550 Kontich, BelgiumKBO/BCE: BE 0879.130.202
Summary

The computed 12-month bankruptcy probability of MEDECO is 6.1% (elevated). The 2025 annual accounts show negative equity (-€2.7m) and a net result of -€5.8m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 5451 sector peers (fiscal year 2025). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
#10 company by total assets in Kontich, Wholesale and retail trade sector1 site
Size
€5.7mturnover 2025
Staff
2.6 FTE
Equity
-€2.7m
Loss
-€5.8m
Financial health
33 Weak Checked score 2025
Bankruptcy chance 12 m
6.1%
Structure
Parent
Mediq International BV · 100%
Board
1 member
Holdings
1
Auditor: KPMG Bedrijfsrevisoren BVAccounts filed 45 d late
Why 33- Loss of €5.8m (FY 2025)- Negative equity -€2.7m- Liquidity: current ratio 0.06, cash €81,463, halved- Latest accounts 45 days late; 3 of the last 3 lateShow the evidence

Checked score

Score 2025
33 / 100
Weak
Probability in this band: 4.2% to 15.0%
Better than 9% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Weak
Solvency 12-24
equity -12.5% of total assets
Liquidity 0-50
short-term debt 111.0% · cash 0.4%
Profitability 0-44
return on assets -27.4%
Bankruptcy probability, 12 months
6.1% Elevated
0%0.5%1.5%4%10%≥ 25%

About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,765 companies)
Last 14 months 09-2025: 6.4%highest value 10-2025: 1.7%▼ -73.5% vs 09-2025 11-2025: 1.7%● 0.0% vs 10-2025 12-2025: 1.7%● 0.0% vs 11-2025 01-2026: 1.7%● 0.0% vs 12-2025 02-2026: 1.7%▼ -3.2% vs 01-2026 03-2026: 1.6%▼ -1.8% vs 02-2026 04-2026: 1.7%▲ +3.9% vs 03-2026 05-2026: 1.9%▲ +12.0% vs 04-2026 06-2026: 1.0%▼ -45.1% vs 05-2026lowest value 07-2026: 1.0%▲ +0.6% vs 06-2026 08-2026: 1.6%▲ +55.5% vs 07-2026 09-2026: 6.2%▲ +280% vs 08-2026 10-2026: 6.1%▼ -0.4% vs 09-2026
  • Loss of €5.8m (FY 2025) raises the probability
  • Negative equity -€2.7m raises the probability
  • Liquidity: current ratio 0.06, cash €81,463, halved raises the probability
  • Latest accounts 45 days late; 3 of the last 3 late raises the probability
No credit on open account
Liquidity short (current ratio 0.06 against 0.85 in 2024; short-term debt: 111% and cash: 0.4% of total assets), and equity is negative.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 13%, liquidity 3%, profitability 6%, growth against the median 12%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Loss of €5.8m (FY 2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Negative equity -€2.7m
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Liquidity: current ratio 0.06, cash €81,463, halved
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Latest accounts 45 days late; 3 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€2.7m
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-09-2026, 45 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
45 d late
2024
50 d late
2023
139 d late
2022
34 d early
2021
54 d early
2020
60 d early
2019
46 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 6 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 14 September (4 of the last 5 filed years within 95 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Reappointment: KPMG Bedrijfsrevisoren BV (statutory auditor)Power of attorney
  3. Weakest financial yearnet -€5.8m

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€2.7m View
  • Caution: From profit to loss in 2025after €728,400 in 2024 -€5.8m View
  • Caution: Among the weakest 5% on solvencysector median 45.7% · 5,451 companies -12.5% View
  • Controlled by Mediq International BVknown shareholders 100% 100% View

By topic

Financials

Fiscal year
2025
Turnover
€5.7m
Loss
-€5.8m
Solvency
-12.5%
Turnover▼ 20.0%
Net result
20182025
Go to Financials

Board & ownership

Board
1 member
Parent
Mediq International BV · 100%
Known shareholders
100%
Auditor
KPMG Bedrijfsrevisoren BV
Go to Board & ownership

Timeline

Events
40
Since
2007
Next accounts
by 31-07-2027
  1. 14-09-2026Annual accounts filed
  2. 15-01-2026Reappointment: KPMG Bedrijfsrevisoren BV (statutory auditor)
  3. 31-12-2025Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
03-02-2006
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
1
Purpose
De import, de export, de distributie en de groot- en kleinhandel in farmaceutische en…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.